Biogen (BIIB) Net Income towards Common Stockholders (2009 - 2026)
Biogen (BIIB) recorded Net Income towards Common Stockholders of -$20.6 million in Q3 2026, compared with $466.5 million a year earlier.
Powered by 
Analysis
Biogen (BIIB) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
On a TTM basis, Biogen's Net Income towards Common Stockholders came in at $347.5 million as of Sep 30, 2026, down 78.4% year-over-year; for FY2025, it came in at $1.29 billion, down 20.8% from FY2024.
- Annual Net Income towards Common Stockholders has a five-year compound annual growth rate of -20.2% (FY2020 to FY2025).
- Across earlier years, Net Income towards Common Stockholders came in at $1.63 billion in FY2024 (+40.6%), $1.16 billion in FY2023 (-61.9%), $3.05 billion in FY2022 (+95.8%) and $1.56 billion in FY2021 (-61.1%).
- Quarterly Net Income towards Common Stockholders has ranged from -$68.1 million in Q3 2023 to $1.13 billion in Q3 2022 over the past five years.
- On a year-over-year basis, Net Income towards Common Stockholders rose in four of the last six quarters, with an average decline of 9.2%.
- Peak year-over-year performance for Net Income towards Common Stockholders in the last five years was growth of 244.7% in Q3 2022, against a decline of 84.6% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $97.5 million (Q2 2026), $319.5 million (Q1 2026) and -$48.9 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | -20.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -20.60 Mn |
| Jun 30, 2026 | 97.50 Mn |
| Mar 31, 2026 | 319.50 Mn |
| Dec 31, 2025 | -48.90 Mn |
| Sep 30, 2025 | 466.50 Mn |
| Jun 30, 2025 | 634.80 Mn |
| Mar 31, 2025 | 240.50 Mn |
| Dec 31, 2024 | 266.70 Mn |
| Sep 30, 2024 | 388.50 Mn |
| Jun 30, 2024 | 583.60 Mn |
| Mar 31, 2024 | 393.40 Mn |
| Dec 31, 2023 | 249.70 Mn |
| Sep 30, 2023 | -68.10 Mn |
| Jun 30, 2023 | 591.60 Mn |
| Mar 31, 2023 | 387.90 Mn |
| Dec 31, 2022 | 550.40 Mn |
| Sep 30, 2022 | 1.13 Bn |
| Jun 30, 2022 | 1.06 Bn |
| Mar 31, 2022 | 303.80 Mn |
| Dec 31, 2021 | 368.20 Mn |
API Access
Biogen Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();